Pharmaceuticals vs Covid-19 | Half-Time Report by Sid Masters, Masters Pharma

As many countries continue to pass the peak of COVID-19, Masters Speciality Pharma’s Head of Licensing, Sid Masters believes now is a good time to reflect on the challenges, successes and response of the pharmaceutical industry during the pandemic.  Sid writes: Over the past few months we have seen Covid-19 wreak havoc by crippling our […]

Recommendations following our EU Healthcare Investor Survey 2020

The Optimum Strategic Communications European VC Report confirmed that there is a substantial amount of money available for investment in European companies. We spoke to 24 of the most influential European VCs, investing approximately EUR 15.5 billion in aggregate in the Healthcare sector, who are actively seeking and reviewing new opportunities. However in the current […]

Optimum Video Q&A: Getting to know Renee Aguiar-Lucander

Since taking over as CEO of Calliditas Therapeutics in 2017, Renee Aguiar-Lucander has taken the biotech through an IPO in Stockholm and commenced a pivotal phase 3 trial plus major licensing deals and a secondary fund raise.  She has established a US presence, made transformational regulatory milestones, and this month completed a successful upsized US […]

Sounding out experts on new treatments for the silent epidemic of COPD

Are you sitting comfortably? Do you notice your breathing, all nice and easy? Now, try taking a straw and breathing just through that. Not quite so easy is it?

Applications for BaseLaunch Phase II accelerator program to close on 22nd June

This is a fantastic initiative that helps young businesses by providing the support they need to succeed. This includes up to USD 500,000 in fundraising, introduction to a dynamic network and access to free lab space.